NYBC Ventures
North America, Massachusetts, United States, Boston
Description
NYBC Ventures to accelerate innovation in blood-related fields and cellular therapies.
Investor Profile
NYBC Ventures has backed more than 14 startups, with 2 new investments in the last 12 months alone. The firm has led 6 rounds, about 43% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series C rounds (top funding stages).
- Majority of deals are located in United States, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Seed (43%)
- Series Unknown (36%)
- Series C (7%)
- Series A (7%)
- Series B (7%)
Country Focus
- United States (93%)
- The Netherlands (7%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Life Science
- Bioinformatics
- Test And Measurement
- Pharmaceutical
- Emergency Medicine
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.